Clean Water Act Section 303(d): Availability of List Decisions
This notice announces the availability of EPA's response to public comments concerning EPA's July 17, 2008 public notice announcing the availability of EPA's decision to add Corpus Christi Bay (Segment 2481) to the Texas 2008 section 303(d) list. On July 17, 2008 EPA published a notice in the Federal Register at 73 FR 41069 providing the public the opportunity to review its decision to add Corpus Christi Bay to the Texas 2008 section 303(d) list as required by EPA's public participation regulations (40 CFR part 25). Based on its review of public comments received in response to this public notice, EPA has decided to maintain the listing of Corpus Christi Bay on the State's 303(d) list but has amended the scope of the listing to geographically define the impairment as restricted to only the Ropes Park and Cole Park Beach portions of Corpus Christi Bay as presently delineated by the Texas Beach Watch Program. Likewise, EPA has re-categorized the listing of the Ropes Park and Cole Park Beach portions of Corpus Christi Bay in category 5c of the State's integrated report. The basis for these decisions is described in EPA's response to public comments and EPA's letter, dated November 12, 2008, to Mr. Mark Vickery, Executive Director, Texas Commission on Environmental Quality (TCEQ).
Amendment to the Universal Waste Rule: Addition of Pharmaceuticals
EPA is proposing to add hazardous pharmaceutical wastes to the Universal Waste Rule. The Universal Waste Rule, originally promulgated on May 11, 1995, modified the Resource Conservation and Recovery Act's hazardous waste regulations by establishing a set of streamlined requirements for the collection of certain widely dispersed hazardous wastes, called ``universal wastes.'' This proposed rule would facilitate better management of pharmaceutical wastes by streamlining the generator requirements and encouraging generators of hazardous pharmaceutical wastes to manage them under the provisions of the Universal Waste Rule, which ensures that these hazardous pharmaceutical wastes are properly disposed of and treated as hazardous wastes. In addition, this proposed rule would facilitate the implementation of pharmaceutical take-back programs by removing RCRA barriers in the collection of pharmaceutical wastes from health care and other such regulated facilities, as well as facilitate the collection of pharmaceutical wastes from households, including non-hazardous pharmaceutical wastes.